Thierry Levade

16.4k total citations · 1 hit paper
287 papers, 12.2k citations indexed

About

Thierry Levade is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Thierry Levade has authored 287 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Molecular Biology, 120 papers in Physiology and 67 papers in Cell Biology. Recurrent topics in Thierry Levade's work include Sphingolipid Metabolism and Signaling (130 papers), Lysosomal Storage Disorders Research (97 papers) and Lipid Membrane Structure and Behavior (45 papers). Thierry Levade is often cited by papers focused on Sphingolipid Metabolism and Signaling (130 papers), Lysosomal Storage Disorders Research (97 papers) and Lipid Membrane Structure and Behavior (45 papers). Thierry Levade collaborates with scholars based in France, United States and Canada. Thierry Levade's co-authors include Nathalie Andrieu‐Abadie, Robert Salvayre, Jean‐Pierre Jaffrézou, Bruno Ségui, Stéphane Carpentier, Olivier Cuvillier, Patrice Codogno, Anne Nègre‐Salvayre, Virginie Garcia and Guy Laurent and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Thierry Levade

284 papers receiving 12.0k citations

Hit Papers

A Review of Gaucher Disea... 2017 2026 2020 2023 2017 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thierry Levade 7.9k 3.3k 2.4k 1.8k 1.5k 287 12.2k
Alicja Bielawska 10.1k 1.3× 2.1k 0.6× 2.5k 1.0× 775 0.4× 1.2k 0.8× 144 11.6k
Jacek Bielawski 9.3k 1.2× 2.1k 0.6× 2.9k 1.2× 1.4k 0.8× 1.0k 0.7× 144 11.1k
Yasuyuki Igarashi 11.5k 1.5× 2.4k 0.7× 3.8k 1.5× 709 0.4× 1.4k 1.0× 252 13.7k
João A. Paulo 8.4k 1.1× 1.6k 0.5× 1.9k 0.8× 2.7k 1.5× 1.4k 0.9× 317 13.2k
Anthony H. Futerman 12.8k 1.6× 6.4k 1.9× 5.3k 2.2× 2.1k 1.2× 1.3k 0.9× 282 18.3k
Matthias P. Wymann 9.0k 1.1× 1.4k 0.4× 1.7k 0.7× 832 0.5× 3.9k 2.7× 138 14.6k
Hugh Rosen 9.7k 1.2× 1.4k 0.4× 2.1k 0.9× 1.5k 0.8× 5.3k 3.6× 198 16.4k
Hisashi Hidaka 7.4k 0.9× 1.6k 0.5× 1.5k 0.6× 1.1k 0.6× 782 0.5× 272 12.8k
David J. Shapiro 5.9k 0.8× 2.0k 0.6× 1.1k 0.5× 669 0.4× 845 0.6× 188 9.9k
Ella Bossy‐Wetzel 11.9k 1.5× 1.9k 0.6× 1.8k 0.7× 1.8k 1.0× 1.4k 0.9× 69 16.1k

Countries citing papers authored by Thierry Levade

Since Specialization
Citations

This map shows the geographic impact of Thierry Levade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Levade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Levade more than expected).

Fields of papers citing papers by Thierry Levade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Levade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Levade. The network helps show where Thierry Levade may publish in the future.

Co-authorship network of co-authors of Thierry Levade

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Levade. A scholar is included among the top collaborators of Thierry Levade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Levade. Thierry Levade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabourdy, Frédérique, et al.. (2024). Human genetic defects of sphingolipid synthesis. Journal of Inherited Metabolic Disease. 48(1). e12745–e12745. 5 indexed citations
2.
McKillop, William M., et al.. (2023). Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions. Biomolecules. 13(2). 274–274. 10 indexed citations
3.
Leclerc, Delphine, Sylvie Jaillard, Léna Damaj, et al.. (2023). Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient. The CRISPR Journal. 6(1). 17–31. 2 indexed citations
4.
Garcia, Virginie, et al.. (2023). Phosphorus Dendrimers for Metal‐Free Ligation: Design of Multivalent Pharmacological Chaperones against Gaucher Disease. Chemistry - A European Journal. 29(53). e202301210–e202301210. 6 indexed citations
5.
Astudillo, L., Magali Pettazzoni, David Cheillan, et al.. (2022). Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer. Cancers. 14(19). 4858–4858. 2 indexed citations
6.
Lee, Michelle M., Darryl C. De Vivo, Daniel Friedman, et al.. (2022). The clinical spectrum of SMA‐PME and in vitro normalization of its cellular ceramide profile. Annals of Clinical and Translational Neurology. 9(12). 1941–1952. 5 indexed citations
7.
Germain, Dominique P., Thierry Levade, Bertrand Knebelmann, et al.. (2021). Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease. Clinical Genetics. 101(4). 390–402. 46 indexed citations
8.
Belleri, Mirella, Daniela Coltrini, Roberto Ronca, et al.. (2020). β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism. Cancer Research. 80(22). 5011–5023. 15 indexed citations
9.
Montfort, Anne, Thomas Filleron, Cécile Pagès, et al.. (2020). Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial. Clinical Cancer Research. 27(4). 1037–1047. 70 indexed citations
10.
Pellerin, Laurence, Laurence Nieto, Bruno Ségui, et al.. (2020). Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives. Cancers. 12(11). 3147–3147. 46 indexed citations
11.
Kraoua, Ichraf, et al.. (2020). Farber disease: A Fatal Childhood Disorder with Nervous System Involvement. 5(3). 1–4. 1 indexed citations
12.
Montfort, Anne, et al.. (2020). New Insights into the Role of Sphingolipid Metabolism in Melanoma. Cells. 9(9). 1967–1967. 21 indexed citations
13.
Garandeau, David, J. C. Leclerc, Caroline Imbert, et al.. (2018). Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas. Molecular Cancer Therapeutics. 18(2). 289–300. 26 indexed citations
14.
Terrasso, Ana Paula, Daniel Simão, Christina Begon‐Pescia, et al.. (2018). Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons. Scientific Reports. 8(1). 16644–16644. 15 indexed citations
15.
Pettazzoni, Magali, Roseline Froissart, Cécile Pagan, et al.. (2017). LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease. PLoS ONE. 12(7). e0181700–e0181700. 49 indexed citations
16.
Bertrand, Florie, Céline Colacios, Anne Montfort, et al.. (2015). Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma. Cancer Research. 75(13). 2619–2628. 88 indexed citations
17.
Bedia, Carmen, Josefina Casas, Nathalie Andrieu‐Abadie, Gemma Fabriàs, & Thierry Levade. (2011). Acid Ceramidase Expression Modulates the Sensitivity of A375 Melanoma Cells to Dacarbazine. Journal of Biological Chemistry. 286(32). 28200–28209. 69 indexed citations
18.
Héron, Bénédicte, Yann Mikaeloff, Roseline Froissart, et al.. (2010). Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. American Journal of Medical Genetics Part A. 155(1). 58–68. 128 indexed citations
19.
Colié, Sandra, Paul P. Van Veldhoven, Blandine Kedjouar, et al.. (2009). Disruption of Sphingosine 1-Phosphate Lyase Confers Resistance to Chemotherapy and Promotes Oncogenesis through Bcl-2/Bcl-xL Upregulation. Cancer Research. 69(24). 9346–9353. 96 indexed citations
20.
Sabourdy, Frédérique, Helen Michelakakis, Aris Anastasakis, et al.. (2009). Danon disease: Further clinical and molecular heterogeneity. Muscle & Nerve. 39(6). 837–844. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026